While IFNLs have been shown to skew T lymphocyte responses, their impact in treated HIV, in particular the potential for IFNL4 expression to modulate the CD4+:CD8+ T-cell ratio in the context of treated HIV-1 infection has not been explored to date. This evidence concerns the gene CD8A and HIV-1 infection.